Roivant Executive and Leadership Team

June, 2026

Leadership Overview

Roivant has 5 executives leading key functions including strategy, information technology, operations, medical affairs, and general management.

Driven by a commitment to patient well-being, Roivant focuses on accelerating the development of promising drug candidates and delivering innovative healthcare technologies, aiming to transform patient care through scientific advancement and operational excellence.

Leadership Roles at Roivant

  • Chief Executive Officer - Matthew Gline
  • Chief Operating Officer (Roivant Platforms) - Stephanie Griffin
  • President - Eric Venker
  • Chief Information Officer - Ian Rosenblum
  • Chief Medical Officer, -Residence - Deya Corzo
  • Matthew Gline - Chief Executive Officer

    Matthew Gline, the Chief Executive Officer at Roivant, directs the company's overarching strategy and operational execution. Gline guides Roivant's mission to advance late-stage drug candidates and integrate innovative healthcare technologies, ensuring alignment with patient needs and market opportunities. Overseeing all business units, the Chief Executive Officer drives the company's growth trajectory and financial performance. This leadership position involves fostering a culture of innovation and accountability across the organization. By championing strategic partnerships and resource allocation, Matthew Gline ensures the efficient progression of Roivant's diverse pipeline, solidifying the company's position as a leader in tech-enabled healthcare solutions.
    Matthew Gline

    Stephanie Griffin - Chief Operating Officer (Roivant Platforms)

    Stephanie Griffin, the Chief Operating Officer (Roivant Platforms) at Roivant, spearheads the operational execution of Roivant's platform companies. Griffin ensures efficient resource deployment and strategic alignment across the portfolio, driving the completion of late-stage drug development programs. Overseeing platform operations, the Chief Operating Officer (Roivant Platforms) optimizes processes for maximum impact and speed. This leadership function involves managing cross-functional teams and fostering collaboration to overcome development hurdles. By streamlining operational workflows, Stephanie Griffin accelerates the delivery of innovative healthcare technologies to patients, reinforcing Roivant's commitment to transforming healthcare.
    Stephanie Griffin

    Eric Venker - President

    Eric Venker, the President at Roivant, drives strategic initiatives and operational excellence across the organization. Venker focuses on enhancing the company's capabilities in completing late-stage drug development and delivering novel healthcare technologies. Overseeing key strategic projects, the President ensures efficient execution and resource allocation to maximize impact. This leadership position involves fostering strong relationships with stakeholders and advancing Roivant's overall business objectives. By championing innovation and operational rigor, Eric Venker plays a vital role in Roivant's mission to bring transformative healthcare solutions to patients worldwide.
    Eric Venker

    Ian Rosenblum - Chief Information Officer

    Ian Rosenblum, the Chief Information Officer at Roivant, architects the company's technology infrastructure and digital strategy. Rosenblum ensures robust data management, cybersecurity, and scalable IT systems to support Roivant's drug development and healthcare technology initiatives. Overseeing all technology operations, the Chief Information Officer drives digital transformation and enhances operational efficiency. This role involves implementing advanced analytics and AI solutions to accelerate research and development processes. By managing the company's technological resources, Ian Rosenblum enables seamless data integration and secure information flow across all departments, directly supporting Roivant's mission to deliver innovative healthcare solutions.
    Ian Rosenblum

    Deya Corzo - Chief Medical Officer, -Residence

    Deya Corzo, the Chief Medical Officer, -Residence at Roivant, provides critical medical and scientific leadership for drug development programs. Corzo guides clinical strategy and ensures the scientific integrity of late-stage candidates, aligning medical insights with patient needs. Overseeing clinical research, the Chief Medical Officer, -Residence drives the evaluation of therapeutic potential and safety profiles. This role involves close collaboration with R&D teams and external medical experts to advance promising treatments. By applying deep medical expertise, Deya Corzo contributes significantly to Roivant's mission of delivering innovative healthcare technologies and improving patient outcomes.

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding Roivant Top Executives and Leadership Team

    Who leads Roivant?
    Roivant is led by Matthew Gline (Chief Executive Officer), along with executives such as Stephanie Griffin (Chief Operating Officer (Roivant Platforms)) and Eric Venker (President).
    Who is part of Roivant’s executive team?
    The executive team of Roivant includes leaders such as Matthew Gline (Chief Executive Officer), Stephanie Griffin (Chief Operating Officer (Roivant Platforms)), Eric Venker (President) and other senior executives.
    How many executives does Roivant have?
    Roivant has 5 executives leading key business areas.
    What roles are included in Roivant’s leadership team?
    The leadership team of Roivant includes roles such as Chief Executive Officer, Chief Operating Officer (Roivant Platforms), President, Chief Information Officer, Chief Medical Officer, -Residence.